Leflaw.com

Skip to content

You are here: Home

Avandia

Avandia, approved by the FDA in 1999, was developed to help control blood sugar in adults with Type 2 Diabetes. The drug is used by millions worldwide.

In 2007, The New England Journal of Medicine detailed an analysis of clinical trials suggesting that the drug significantly increases the risk of heart attacks and cardiovascular death. The study was conducted by doctors at the renowned Cleveland Clinic and was published on May 21, 2007.

The trials compared patients taking Avandia with those not using the drug. The results indicate that Avandia users had an increase of cardiac-related deaths by 64 percent and 43 percent increase in heart attacks.

On May 21, 2007, the U.S. Food and Drug Administration said patients taking Avandia, especially those with heart disease or at high risk of heart attack, should talk to their doctor about the risks. Since the drug was approved, the FDA has monitored several heart-related adverse events associated with Avandia, such as fluid retention, edema and congestive heart failure.

Fill Out a Form

Defective Drugs Form

Basic Information

Name

Email

Phone

State of Residence

DOB

Details About Injury

Drug Complained of:

When Did You Take This Drug?

Describe Your Injury

Are you human?

FDA Recalls

Food and Drug Administration--Recalls/Safety Alerts

Bakery El Monte Sinai Corp Announces Allergy Alert on Undeclared Eggs in Rainbow Cake
Bakery El Monte Sinai Corp., located at 100 A North Franklin Street in Hempstead, New York 11550, is recalling rainbow cake because it may contain undeclared eggs.
Hospira Announces A Nationwide Voluntary Recall Of One Lot Of Hydromorphone Hydrochloride Injection 1 MG/ML, (C-II) 1 ML Fill In 2.5 ML Carpuject, That May Contain More Than The Intended Fill Volume
Hospira, Inc. (NYSE: HSP), announced today it is initiating a voluntary user level recall of one lot of Hydromorphone Injection, USP, 1 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject, NDC 0409-1283-31, due to two reported complaints of a single Carpuject containing more than the 1 mL labeled fill volume. Opioid pain medications such as Hydromorphone have life-threatening consequences if overdosed.
NestlÃ© Purina Voluntarily Recalls Single Lot of Therapeutic Canned Cat Food Due to A Low Level of Thiamine (Vitamin B1)
NestlÃ© Purina PetCare (NPP) is voluntarily recalling one specific lot of its Purina Veterinary DietsÂ® OM Overweight Management canned cat food, available through veterinarians in the U.S. and Canada. This precautionary measure is being taken in response to one consumer complaint received by FDA.